Table 2: Anthropometric measurements and clinical parameters of the study sample in Qatar ( ).

Variables Total
= 1,552
ATPIII valueIDF value
MetS(+)
MetS(−)
MetS(+)
MetS(−)
(%) (%) (%) (%) (%)

Waist circumference (cm)97.13 ± 12.40106.04 ± 10.1793.97 ± 11.56<0.00198.87 ± 13.2396.11 ± 11.78<0.001
Hip circumference (cm)110.02 ± 9.87113.58 ± 10.27108.75 ± 9.42<0.001110.62 ± 10.85109.67 ± 9.240.068
Height (cm)162.84 ± 9.65162.33 ± 10.03163.02 ± 9.510.215162.84 ± 9.65162.37 ± 9.570.139
Weight (Kg)77.51 ± 15.9783.35 ± 16.9275.44 ± 15.09<0.00178.92 ± 18.1076.69 ± 14.520.008
Waist hip ratio (WHR)0.88 ± 0.090.94 ± 0.080.86 ± 0.08<0.0010.89 ± 0.090.88 ± 0.09<0.001
Waist height ratio0.60 ± 0.080.66 ± 0.070.58 ± 0.08<0.0010.61 ± 0.090.59 ± 0.08<0.001
Body mass index (Kg/m2)29.32 ± 6.1031.87 ± 7.1128.42 ± 5.41<0.00130.10 ± 7.3128.86 ± 5.21<0.001
Body mass index: (%)
 <25377 (24.3)72 (17.7)305 (26.6)<0.001164 (28.7)213 (21.7)<0.001
 25–29.9512 (33.0)96 (23.6)416 (36.3)127 (22.2)385 (39.3)
 ≥30663 (42.7)238 (58.6)425 (37.1)281 (49.1)382 (39.0)
Fasting glucose (mmol/L)6.26 ± 2.548.31 ± 3.435.54 ± 1.62<0.0016.97 ± 3.045.85 ± 1.30<0.001
Haemoglobin A1c (%)6.11 ± 1.597.36 ± 1.935.67 ± 1.18<0.0016.58 ± 1.925.84 ± 1.30<0.001
Total cholesterol (mmol/L)4.86 ± 0.835.00 ± 0.834.81 ± 0.82<0.0014.93 ± 0.844.81 ± 0.820.006
HDL cholesterol (mmol/L)1.40 ± 0.331.32 ± 0.271.42 ± 0.34<0.0011.36 ± 0.301.42 ± 0.340.001
LDL cholesterol (mmol/L)2.81 ± 0.702.88 ± 0.682.79 ± 0.700.0322.83 ± 0.712.80 ± 0.690.552
Triglycerides (mmol/L)1.41 ± 0.811.63 ± 0.821.34 ± 0.79<0.0011.48 ± 0.761.37 ± 0.830.010
Systolic blood pressure (mmHg)127.36 ± 16.00131.57 ± 15.41125.87 ± 15.95<0.001128.58 ± 16.23126.65 ± 15.840.023
Diastolic blood pressure (mmHg)79.23 ± 9.7582.16 ± 9.4278.19 ± 9.65<0.00180.32 ± 10.1878.59 ± 9.43<0.001